Two New Bills Present Challenges to DNA Patentability

Two New Bills Present Challenges to DNA Patentability This time the challenge to the patents, commonly called gene patents, comes from the US House of Representatives in the form of two bills introduced on March 15 by Rep. Lynn Rivers (D-Mich.). If enacted, each of these would threaten future biotech innovation in the US.




Click here for reuse options!
Copyright 2002 Biotechblog

Biotech industry's still waiting to break out

Biotech industry’s still waiting to break out It turns out that even with the genome in hand, discovering drugs and testing them to prove they work is an expensive, grueling process.




Click here for reuse options!
Copyright 2002 Biotechblog

Biotech industry’s still waiting to break out

Biotech industry’s still waiting to break out It turns out that even with the genome in hand, discovering drugs and testing them to prove they work is an expensive, grueling process.




Click here for reuse options!
Copyright 2002 Biotechblog

Rating the Nation's Best and Worst Jobs

Rating the Nation’s Best and Worst Jobs According to this year’s edition of “Jobs Rated Almanac” the nation’s single best job in terms of low stress, high compensation, lots of autonomy, tremendous hiring demand and several other key criteria, is biologist.




Click here for reuse options!
Copyright 2002 Biotechblog

Rating the Nation’s Best and Worst Jobs

Rating the Nation’s Best and Worst Jobs According to this year’s edition of “Jobs Rated Almanac” the nation’s single best job in terms of low stress, high compensation, lots of autonomy, tremendous hiring demand and several other key criteria, is biologist.




Click here for reuse options!
Copyright 2002 Biotechblog

Motorola shedding biochip biz

Motorola shedding biochip biz Motorola Inc. has put its life sciences business up for sale in a move that is dashing CEO Christopher Galvin’s dream of making biochips the company’s next big success.




Click here for reuse options!
Copyright 2002 Biotechblog

Drug makers need a cure for the manufacturing crunch

Drug makers need a cure for the manufacturing crunch Over the next several years, growth in demand for biotech production is estimated to outstrip the growth in supply.




Click here for reuse options!
Copyright 2002 Biotechblog

Celera Shifts Marketing of Database

Celera Shifts Marketing of Database The main job of marketing and distributing the database will be shifted to Celera’s sister company, the Applied Biosystems Group, which makes equipment used to study genes and proteins




Click here for reuse options!
Copyright 2002 Biotechblog

Was the U.S. government cheated on DNA decoder?

Was the U.S. government cheated on DNA decoder? The scribblings of Henry Huang helped start the great race to map the human genome, and they may help settle allegations that the U.S. government got robbed on the way to the finish.




Click here for reuse options!
Copyright 2002 Biotechblog

%d bloggers like this: